CME Group's Revenue
- CME Group's annual revenue was $6.52 B in fiscal year 2025. The annual revenue increased $390.50 M from $6.13 B (in 2024) to $6.52 B (in 2025), representing a 6.37% year-over-year growth.
- CME Group's quarterly revenue was $1.65 B in the quarter ending Dec 2025. The quarterly revenue increased $123.40 M from $1.53 B (in Q4: Sept 2024) to $1.65 B (in Q4: Sept 2025), representing a 8.09% year-over-year growth.
- The highest annual revenue for CME Group was $6.52 B in fiscal year 2025.
- The lowest annual revenue was $3.60 B in fiscal year 2016.
- The average revenue was $4.92 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2016 - 2025):
Learn more about CME Group's Revenue by Segment and Revenue by Region.
Check out competitors to CME Group in a side-by-side comparison.
Explore additional financial metrics for CME Group.
Definition of Revenue :
CME Group's Revenue Trend
| 2015 | 3326800000.00 |
|---|---|
| 2016 | 3595200000.00 |
| 2017 | 3644700000.00 |
| 2018 | 4309400000.00 |
| 2019 | 4868000000.00 |
| 2020 | 4883600000.00 |
| 2021 | 4689700000.00 |
| 2022 | 5019400000.00 |
| 2023 | 5578900000.00 |
| 2024 | 6130100000.00 |
| 2025 | 6520600000.00 |
| Mar 2016 | 934200000.00 |
|---|---|
| Jun 2016 | 906400000.00 |
| Sep 2016 | 841700000.00 |
| Dec 2016 | 912900000.00 |
| Mar 2017 | 929300000.00 |
| Jun 2017 | 924600000.00 |
| Sep 2017 | 890800000.00 |
| Dec 2017 | 900000000.00 |
| Mar 2018 | 1109000000.00 |
| Jun 2018 | 1059600000.00 |
| Sep 2018 | 904200000.00 |
| Dec 2018 | 1236600000.00 |
| Mar 2019 | 1179600000.00 |
| Jun 2019 | 1272700000.00 |
| Sep 2019 | 1277300000.00 |
| Dec 2019 | 1138400000.00 |
| Mar 2020 | 1522100000.00 |
| Jun 2020 | 1182300000.00 |
| Sep 2020 | 1080700000.00 |
| Dec 2020 | 1098500000.00 |
| Mar 2021 | 1253300000.00 |
| Jun 2021 | 1179200000.00 |
| Sep 2021 | 1109900000.00 |
| Dec 2021 | 1147300000.00 |
| Mar 2022 | 1346600000.00 |
| Jun 2022 | 1237200000.00 |
| Sep 2022 | 1227800000.00 |
| Dec 2022 | 1207800000.00 |
| Mar 2023 | 1441600000.00 |
| Jun 2023 | 1360200000.00 |
| Sep 2023 | 1337800000.00 |
| Dec 2023 | 1439300000.00 |
| Mar 2024 | 1487900000.00 |
| Jun 2024 | 1532500000.00 |
| Sep 2024 | 1584400000.00 |
| Dec 2024 | 1525300000.00 |
| Mar 2025 | 1642300000.00 |
| Jun 2025 | 1692000000.00 |
| Sep 2025 | 1537600000.00 |
| Dec 2025 | 1648700000.00 |
2025
CME Group's annual revenue was $6.52 B in fiscal year 2025.
CME Group's quarterly revenue was $1.64 B(Q1: Mar 2025), $1.69 B(Q2: Jun 2025), $1.54 B(Q3: Sep 2025), $1.65 B(Q4: Dec 2025) in fiscal year 2025.
2024
CME Group's annual revenue was $6.13 B in fiscal year 2024.
CME Group's quarterly revenue was $1.49 B(Q1: Mar 2024), $1.53 B(Q2: Jun 2024), $1.58 B(Q3: Sep 2024), $1.53 B(Q4: Dec 2024) in fiscal year 2024.
2023
CME Group's annual revenue was $5.58 B in fiscal year 2023.
CME Group's quarterly revenue was $1.44 B(Q1: Mar 2023), $1.36 B(Q2: Jun 2023), $1.34 B(Q3: Sep 2023), $1.44 B(Q4: Dec 2023) in fiscal year 2023.
2022
CME Group's annual revenue was $5.02 B in fiscal year 2022.
CME Group's quarterly revenue was $1.35 B(Q1: Mar 2022), $1.24 B(Q2: Jun 2022), $1.23 B(Q3: Sep 2022), $1.21 B(Q4: Dec 2022) in fiscal year 2022.
2021
CME Group's annual revenue was $4.69 B in fiscal year 2021.
CME Group's quarterly revenue was $1.25 B(Q1: Mar 2021), $1.18 B(Q2: Jun 2021), $1.11 B(Q3: Sep 2021), $1.15 B(Q4: Dec 2021) in fiscal year 2021.
2020
CME Group's annual revenue was $4.88 B in fiscal year 2020.
CME Group's quarterly revenue was $1.52 B(Q1: Mar 2020), $1.18 B(Q2: Jun 2020), $1.08 B(Q3: Sep 2020), $1.10 B(Q4: Dec 2020) in fiscal year 2020.
2019
CME Group's annual revenue was $4.87 B in fiscal year 2019.
CME Group's quarterly revenue was $1.18 B(Q1: Mar 2019), $1.27 B(Q2: Jun 2019), $1.28 B(Q3: Sep 2019), $1.14 B(Q4: Dec 2019) in fiscal year 2019.
2018
CME Group's annual revenue was $4.31 B in fiscal year 2018.
CME Group's quarterly revenue was $1.11 B(Q1: Mar 2018), $1.06 B(Q2: Jun 2018), $904.20 M(Q3: Sep 2018), $1.24 B(Q4: Dec 2018) in fiscal year 2018.
2017
CME Group's annual revenue was $3.64 B in fiscal year 2017.
CME Group's quarterly revenue was $929.30 M(Q1: Mar 2017), $924.60 M(Q2: Jun 2017), $890.80 M(Q3: Sep 2017), $900.00 M(Q4: Dec 2017) in fiscal year 2017.
2016
CME Group's annual revenue was $3.60 B in fiscal year 2016.
CME Group's quarterly revenue was $934.20 M(Q1: Mar 2016), $906.40 M(Q2: Jun 2016), $841.70 M(Q3: Sep 2016), $912.90 M(Q4: Dec 2016) in fiscal year 2016.
CME Group's Revenue (Year-over-Year Change)
| 2015 | 0 |
|---|---|
| 2016 | +8.07 |
| 2017 | +1.38 |
| 2018 | +18.24 |
| 2019 | +12.96 |
| 2020 | +0.32 |
| 2021 | -3.97 |
| 2022 | +7.03 |
| 2023 | +11.15 |
| 2024 | +9.88 |
| 2025 | +6.37 |
| Q1: Mar 16 | 10.86 |
|---|---|
| Q2: Jun 16 | 10.54 |
| Q3: Sep 16 | -1.01 |
| Q4: Dec 16 | 12.18 |
| Q1: Mar 17 | -0.52 |
| Q2: Jun 17 | 2.01 |
| Q3: Sep 17 | 5.83 |
| Q4: Dec 17 | -1.41 |
| Q1: Mar 18 | 19.34 |
| Q2: Jun 18 | 14.60 |
| Q3: Sep 18 | 1.50 |
| Q4: Dec 18 | 37.40 |
| Q1: Mar 19 | 6.37 |
| Q2: Jun 19 | 20.11 |
| Q3: Sep 19 | 41.26 |
| Q4: Dec 19 | -7.94 |
| Q1: Mar 20 | 29.04 |
| Q2: Jun 20 | -7.10 |
| Q3: Sep 20 | -15.39 |
| Q4: Dec 20 | -3.50 |
| Q1: Mar 21 | -17.66 |
| Q2: Jun 21 | -0.26 |
| Q3: Sep 21 | 2.70 |
| Q4: Dec 21 | 4.44 |
| Q1: Mar 22 | 7.44 |
| Q2: Jun 22 | 4.92 |
| Q3: Sep 22 | 10.62 |
| Q4: Dec 22 | 5.27 |
| Q1: Mar 23 | 7.05 |
| Q2: Jun 23 | 9.94 |
| Q3: Sep 23 | 8.96 |
| Q4: Dec 23 | 19.17 |
| Q1: Mar 24 | 3.21 |
| Q2: Jun 24 | 12.67 |
| Q3: Sep 24 | 18.43 |
| Q4: Dec 24 | 5.98 |
| Q1: Mar 25 | 10.38 |
| Q2: Jun 25 | 10.41 |
| Q3: Sep 25 | -2.95 |
| Q4: Dec 25 | 8.09 |
2025
CME Group’s annual revenue increased +6.37% during fiscal year 2025 compared to 2024. It represents a growth of $390.50 M from $6.13 B (in 2024) to $6.52 B (in 2025).
2024
CME Group’s annual revenue increased +9.88% during fiscal year 2024 compared to 2023. It represents a growth of $551.20 M from $5.58 B (in 2023) to $6.13 B (in 2024).
2023
CME Group’s annual revenue increased +11.15% during fiscal year 2023 compared to 2022. It represents a growth of $559.50 M from $5.02 B (in 2022) to $5.58 B (in 2023).
2022
CME Group’s annual revenue increased +7.03% during fiscal year 2022 compared to 2021. It represents a growth of $329.70 M from $4.69 B (in 2021) to $5.02 B (in 2022).
2021
CME Group’s annual revenue decreased -3.97% during fiscal year 2021 compared to 2020. It represents a decline of -$193.90 M from $4.88 B (in 2020) to $4.69 B (in 2021).
2020
CME Group’s annual revenue increased +0.32% during fiscal year 2020 compared to 2019. It represents a growth of $15.60 M from $4.87 B (in 2019) to $4.88 B (in 2020).
2019
CME Group’s annual revenue increased +12.96% during fiscal year 2019 compared to 2018. It represents a growth of $558.60 M from $4.31 B (in 2018) to $4.87 B (in 2019).
2018
CME Group’s annual revenue increased +18.24% during fiscal year 2018 compared to 2017. It represents a growth of $664.70 M from $3.64 B (in 2017) to $4.31 B (in 2018).
2017
CME Group’s annual revenue increased +1.38% during fiscal year 2017 compared to 2016. It represents a growth of $49.50 M from $3.60 B (in 2016) to $3.64 B (in 2017).
2016
CME Group’s annual revenue increased +8.07% during fiscal year 2016 compared to 2015. It represents a growth of $268.40 M from $3.33 B (in 2015) to $3.60 B (in 2016).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2025 | $6.52 B | +6.37% |
| 2024 | $6.13 B | +9.88% |
| 2023 | $5.58 B | +11.15% |
| 2022 | $5.02 B | +7.03% |
| 2021 | $4.69 B | -3.97% |
| 2020 | $4.88 B | +0.32% |
| 2019 | $4.87 B | +12.96% |
| 2018 | $4.31 B | +18.24% |
| 2017 | $3.64 B | +1.38% |
| 2016 | $3.60 B | +8.07% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 25 | $1.65 B | 8.09% |
| Q3: Sep 25 | $1.54 B | -2.95% |
| Q2: Jun 25 | $1.69 B | 10.41% |
| Q1: Mar 25 | $1.64 B | 10.38% |
| Q4: Dec 24 | $1.53 B | 5.98% |
| Q3: Sep 24 | $1.58 B | 18.43% |
| Q2: Jun 24 | $1.53 B | 12.67% |
| Q1: Mar 24 | $1.49 B | 3.21% |
| Q4: Dec 23 | $1.44 B | 19.17% |
| Q3: Sep 23 | $1.34 B | 8.96% |
| Q2: Jun 23 | $1.36 B | 9.94% |
| Q1: Mar 23 | $1.44 B | 7.05% |
| Q4: Dec 22 | $1.21 B | 5.27% |
| Q3: Sep 22 | $1.23 B | 10.62% |
| Q2: Jun 22 | $1.24 B | 4.92% |
| Q1: Mar 22 | $1.35 B | 7.44% |
| Q4: Dec 21 | $1.15 B | 4.44% |
| Q3: Sep 21 | $1.11 B | 2.70% |
| Q2: Jun 21 | $1.18 B | -0.26% |
| Q1: Mar 21 | $1.25 B | -17.66% |
| Q4: Dec 20 | $1.10 B | -3.50% |
| Q3: Sep 20 | $1.08 B | -15.39% |
| Q2: Jun 20 | $1.18 B | -7.10% |
| Q1: Mar 20 | $1.52 B | 29.04% |
| Q4: Dec 19 | $1.14 B | -7.94% |
| Q3: Sep 19 | $1.28 B | 41.26% |
| Q2: Jun 19 | $1.27 B | 20.11% |
| Q1: Mar 19 | $1.18 B | 6.37% |
| Q4: Dec 18 | $1.24 B | 37.40% |
| Q3: Sep 18 | $904.20 M | 1.50% |
| Q2: Jun 18 | $1.06 B | 14.60% |
| Q1: Mar 18 | $1.11 B | 19.34% |
| Q4: Dec 17 | $900.00 M | -1.41% |
| Q3: Sep 17 | $890.80 M | 5.83% |
| Q2: Jun 17 | $924.60 M | 2.01% |
| Q1: Mar 17 | $929.30 M | -0.52% |
| Q4: Dec 16 | $912.90 M | 12.18% |
| Q3: Sep 16 | $841.70 M | -1.01% |
| Q2: Jun 16 | $906.40 M | 10.54% |
| Q1: Mar 16 | $934.20 M | 10.86% |
